Testing a new nasal spray for seasonal allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had seasonal allergy symptoms (like sneezing, runny nose, itchy eyes) for at least a few months each year for more than 1 year, and your symptoms are not due to other causes like infections.
- You had a positive skin prick test for ragweed pollen in the last 12 months (where the test area swells at least as big as a pea).
- You are in generally good health, as determined by a doctor based on your medical history and routine tests.
- You do not have any nose problems like nasal polyps, a hole in the septum, or chronic sinusitis.
- You do not have a history of frequent nosebleeds or a condition called rhinitis medicamentosa (nasal spray overuse).
- You do not have current or long-term liver disease, and your heart rhythm test (ECG) shows a normal QT interval.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
This study looks at how seasonal allergies affect the face in adults. It tests a nasal spray and uses facial photos to see how well it works and how it changes allergy symptoms.
This trial tests a new nasal spray designed to relieve the stuffy nose, sneezing, and itching caused by seasonal allergies. It is for people with moderate to severe symptoms that aren’t controlled by other treatments.
This study tests an investigational drug called AK139 to see if it can better control seasonal allergic rhinitis (hay fever) symptoms like sneezing and runny nose. If your symptoms are not well managed with current allergy medicines, this trial might offer a new option.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
Hear when a new Seasonal Allergic Rhinitis (SAR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.